Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

JERUSALEM, July 22, 2019 -- (Healthcare Sales & Marketing Network) -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces top-line data from the Company's pivotal Phase 3 trial (the ACCORDANCE trial) evaluating ... Biopharmaceuticals, Neurology Intec Pharma, Accordion Pill, Carbidopa, Levodopa, Parkinson's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news